United Kingdom (GB)

Learning on the edge: Explicit boundary handling in CNNs (2019) Innamorati C, Ritschel T, Mitra NJ, Weyrich T Conference contribution Preserving ceramic industrial heritage through digital technologies (2019) Echavarria KR, Brownsword N, Weyrich T Conference contribution Glamdring: Automatic application partitioning for intel SGX (2019) Lind J, Priebe C, Muthukumaran D, O'Keeffe D, Aublin PL, Kelbert F, Reiher T, et al. Conference contribution Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. (2019) House AA, Wanner C, Sarnak MJ, Pina IL, Mcintyre CW, Komenda P, Kasiske BL, et al. Journal article The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease - A systematic literature review by a European panel of experts. (2019) Germain DP, Arad M, Burlina A, Elliott PM, Falissard B, Feldt-Rasmussen U, Hilz MJ, et al. Journal article The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts. (2019) Germain DP, Elliott PM, Falissard B, Fomin VV, Hilz MJ, Jovanovic A, Kantola I, et al. Journal article, Review article Coronary Artery Bypass Grafting in Diabetic Patients: Complete Arterial versus Internal Thoracic Artery and Sequential Vein Grafts-A Propensity-Score Matched Analysis. (2019) Kunihara T, Wendler O, Heinrich K, Nomura R, Schaefers HJ Journal article Non-inferiority double-blind randomised controlled trial comparing gabapentin versus tramadol for the treatment of chronic neuropathic or mixed pain in children and adolescents: the GABA-1 trial-a study protocol. (2019) Kaguelidou F, Le Roux E, Mangiarini L, Lundin R, De Leeuw TG, Della Pasqua O, Felisi M, et al. Journal article EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†. (2019) Horwich A, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, et al. Journal article Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. (2019) Scully M, Cataland SR, Peyvandi F, Coppo P, Knobl P, Hovinga JAK, Metjian A, et al. Journal article